way 100135 has been researched along with bicuculline in 2 studies
Studies (way 100135) | Trials (way 100135) | Recent Studies (post-2010) (way 100135) | Studies (bicuculline) | Trials (bicuculline) | Recent Studies (post-2010) (bicuculline) |
---|---|---|---|---|---|
143 | 0 | 34 | 6,253 | 3 | 759 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Furuyashiki, T; Miyamoto, C; Narumiya, S; Ohinata, K; Suzuki, C | 1 |
Kanamoto, R; Mizushige, T; Ohinata, K; Sawashi, Y; Yamada, A | 1 |
2 other study(ies) available for way 100135 and bicuculline
Article | Year |
---|---|
Central PGE2 exhibits anxiolytic-like activity via EP1 and EP4 receptors in a manner dependent on serotonin 5-HT1A, dopamine D1 and GABAA receptors.
Topics: Animals; Anti-Anxiety Agents; Behavior, Animal; Benzazepines; Bicuculline; Brain; Dinoprostone; Flumazenil; GABA Modulators; GABA-A Receptor Antagonists; Male; Mice; Mice, Knockout; Neuropsychological Tests; Piperazines; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine D1; Receptors, GABA-A; Receptors, Prostaglandin E, EP1 Subtype; Receptors, Prostaglandin E, EP4 Subtype; Serotonin Antagonists | 2011 |
Characterization of Tyr-Leu-Gly, a novel anxiolytic-like peptide released from bovine αS-casein.
Topics: Amino Acid Sequence; Animals; Anti-Anxiety Agents; Benzazepines; Bicuculline; Carboxypeptidases; Caseins; Cattle; Dose-Response Relationship, Drug; Gastrointestinal Tract; Male; Maze Learning; Mice; Molecular Sequence Data; Motor Activity; Oligopeptides; Pancreatic Elastase; Pancreatin; Pepsin A; Peptide Hydrolases; Piperazines; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine D1; Receptors, GABA-A; Trypsin | 2013 |